Nutrigenomics in cardiovascular disease: Implications for the future

Progress in Cardiovascular Nursing

Volumn 24, Issue 4, 2009, Pages 190-195

  Engler, Mary B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID;

BLOOD; CARDIOVASCULAR DISEASE; DIET THERAPY; DISEASE COURSE; FAT INTAKE; GENETICS; HUMAN; INFLAMMATION; MEDITERRANEAN DIET; NUTRIGENOMICS; NUTRITIONAL STATUS; REVIEW; RISK FACTOR; UNITED STATES;

CARDIOVASCULAR DISEASES; DIET, MEDITERRANEAN; DIETARY FATS; DISEASE PROGRESSION; HUMANS; INFLAMMATION; LIPIDS; NUTRIGENOMICS; NUTRITIONAL STATUS; RISK FACTORS; UNITED STATES;

EID: 74349110273     PISSN: 08897204     EISSN: 17517117     Source Type: Journal    
DOI: 10.1111/j.1751-7117.2009.00058.x     Document Type: Review

References (25)

1. Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). J Am Med Assoc 2001, 285:2486-2497. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults.
2. Keys A, Menotti A, Karvonen MJ. The diet and 15-year death rate in the seven countries study. Am J Epidemiol 1986, 124:903-915.
3. de Lorgeril M, Salen P, Martin JL. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 1999, 99:779-785.
4. Lairon D. Intervention studies on Mediterranean diet and cardiovascular risk. Mol Nutr Food Res 2007, 51:1209-1214.
5. Sacks FM, Svetkey LP, Vollmer WM. Effects on blood pressure of reduced sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001, 344:3-10.
6. Daniel H, Wenzal U, Brigelius-Flohe R, Joost HG. Nutritional genomics: concepts, tools and expectations. Nutritional Genomics 2006, 3-21. In, eds, Weinheim, WILEY-VCH Verlag GmbH & Co. KGaA
7. Ghosh D, Skinner MA, Laing WA. Pharmacogenomics and nutrigenomics: synergies and differences. Eur J Clin Nutr 2007, 61:567-574.
8. Attia J, Ioannidis JPA, Thakkinstian A. How to use an article about genetic associations, A. Background concepts. JAMA 2009, 301:74-81.
9. Arnett DK, Baird AE, Barkley RA. Relevance of genetics and genomics for prevention and treatment of cardiovascular disease: a scientific statement from the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation 2007, 115:2878-2901.
10. Engler MB, Pullinger C, Malloy M. Genetic variation in PLTP modulates lipoprotein profiles in hyperalphalipoproteinemia. Metabolism 2008, 57:1719-1724.
11. Franchini M, Peyvandi F, Mannucci PM. The genetic basis of coronary artery disease: from candidate genes to whole genome analysis. Trends Cardiovasc Med 2008, 18:157-162.
12. Zhang X, Yap Y, Wei D. Novel omics technologies in mutation research. Biotechnol Adv 2008, 26:169-176.
13. Cho SE, Sook Hong K, Shin GJ. The methylenetetrahydrofolate reductase C677T gene mutation is associated with hyperhomocysteinemia, cardiovascular disease and plasma B-type natriuretic peptide levels in Korea. Clin Chem Lab Med 2006, 44:1070-1075.
14. Ordovas JM, Corella D, Cupples LA. Polyunsaturated fatty acids modulate the effects of the APOA1 G-A polymorphism on HDL-cholesterol concentrations in a sex-specific manner: the Framingham Study. Am J Clin Nutr 2002, 75:38-46.
15. Ordovas JM. Genetic interactions with diet influence the risk of cardiovascular disease. Am J Clin Nutr 2006, 83((suppl)):443S-446S.
16. Willer CJ, Sanna S, Jackson AU. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 2008, 40:161-169.
17. Kathiresan S, Willer CJ, Peloso GM. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 2009, 41:56-65.
18. Junyent M, Parnell LD, Lai CQ. Novel variants at KCTD10, MVK, MMAB genes interact with dietary carbohydrates to modulate HDL-cholesterol concentrations in the Genetics of Lipid Lowering Drugs and Diet Network Study. Am J Clin Nutr 2009, 90((3)):684-694.
19. Ross RR. Atherosclerosis: an inflammatory disease. N Engl J Med 1999, 340:1115-1126.
20. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352:1685-1695.
21. Devaraj S, Singh U, Jialal I. The evolving role of C-reactive protein in atherothrombosis. Clin Chem 2009, 55((2)):229-238.
22. Shen J, Ordovas JM. Impact of genetic and environmental factors on hsCRP concentrations and response to therapeutic agents. Clin Chem 2009, 55((2)):256-264.
23. Dwyer JH, Allayee H, Dwyer KM. Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N Engl J Med 2004, 350:29-37.
24. Bouwens M, van de Rest O, Dellschaft N. Fish-oil supplementation induces anti-inflammatory gene expression profiles in human blood mononuclear cells. Am J Clin Nutr 2009, 90:415-424.
25. Essentials of Genetic and Genomic Nursing: Competencies, Curricula Guidelines, and Outcome Indicators 2009, 1-74. Consensus Panel on Genetic/Genomic Nursing Competencies., Silver Spring, MD, American Nurses Association